Delivery Order SPE2DB20D2002-SPE2DB25FL74X
- Not listed
- The Defense Logistics Agency awarded a $13,493.92 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside basis through competitive procurement, reflecting AmerisourceBergen's established capability to fulfill federal...
- The Defense Logistics Agency awarded a delivery order valued at $27,721.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 29, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,980.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded non-set-aside contract for pharmaceutical supplies to support federal medical procurement needs. The product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,474.62 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed price delivery order, which is not set-aside designated, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,735.65 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,202.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- The Defense Logistics Agency awarded a $80,070.90 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by September 3, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency awarded a $5,014.66 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract will be completed by September 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting the company's demonstrated capability to meet federal procurement requirements...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL74XDelivery Order
The Defense Logistics Agency awarded a $11,848.45 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive experience fulfilling competitive federal medical supply requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 9/9/25 |